Explore our trials
World First Clinical Trial in Inflammatory Bowel Disease
April 22, 2022
SYMBYX, the Australian medical laser company with the world’s first non-pharmaceutical therapy for Parkinson’s, today announced the start of a ground-breaking clinical trial of laser light therapy (photobiomodulation or PBM) on young adults suffering from IBD.
Want the chance to trial unreleased products?
As part of our product development process we invite a small selection of our community to give us their thoughts and feedback.
Want to get involved? Leave us your email address, and we’ll let you know when the next community trial begins.